Author

Quentin Donati

École Nationale Supérieure de Chimie de Montpellier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alain ChavanieuiD· 1 shared Anthony R. MartiniD· 1 shared Baptiste LegrandiD· 1 shared Émilie Rigal· 1 shared Guillaume LacondeiD· 1 shared Jean‐Marc PascussiiD· 1 shared Julie PannequiniD· 1 shared Luc BruneliD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alain ChavanieuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting Pregnane X Receptor with a Potent Agonist-Based PROTAC to Delay Colon Cancer Relapse

Lucile Bansard, Guillaume Laconde, Vanessa Delfosse, Tiphaine Huet, Margaux Ayeul, Émilie Rigal, Quentin Donati, Sabine Gerbal‐Chaloin, Martine Daujat‐Chavanieu, Luc Brunel, Baptiste Legrand, Alain Chavanieu, Anthony R. Martin, Julie Pannequin, William Bourguet, , Jean‐Marc Pascussi

This study designs and tests a PXR agonist-based PROTAC (JMV7048) that degrades PXR in cancer cells, reducing chemoresistance and delaying colon cancer relapse.

Oncogenesis · Aug 30, 2025Peer-reviewedCancer Biology